Cargando…
State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent
SIMPLE SUMMARY: This review discusses the prominent highlights of SH003, a herbal mixture that has the potential to become a notable anticancer agent in the future. Although developing an anticancer drug may take a lengthy approval process for any natural compounds or herbal mixtures to validate the...
Autores principales: | Lee, Kangwook, Youn, Bo-Young, Choi, Yu-Jeong, Moon, Seunghwan, Im, Jungkwun, Cho, Kyongha, Ko, Seong-Gyu, Cheon, Chunhoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870567/ https://www.ncbi.nlm.nih.gov/pubmed/35205836 http://dx.doi.org/10.3390/cancers14041089 |
Ejemplares similares
-
A Phase I Study to Evaluate the Safety of the Herbal Medicine SH003
in Patients With Solid Cancer
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol
por: Cheon, Chunhoo, et al.
Publicado: (2020) -
SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020) -
SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016) -
SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)